^
BIOMARKER:

BRCA2 mutation

i
Other names: BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast cancer 2, early onset
Entrez ID:
Related biomarkers:
BRCA2 mutation
Pancreatic Cancer
BRCA2 mutation
Peritoneal Cancer
BRCA2 mutation
Fallopian Tube Cancer
BRCA2 mutation
Peritoneal Cancer
BRCA2 mutation
Fallopian Tube Cancer
BRCA2 mutation
Peritoneal Cancer
BRCA2 mutation
Fallopian Tube Cancer
BRCA2 mutation
Fallopian Tube Cancer
BRCA2 mutation
Peritoneal Cancer
BRCA2 mutation
Prostate Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
HER2 Negative Breast Cancer
BRCA2 mutation
HER2 Negative Breast Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Prostate Cancer
BRCA2 mutation
Peritoneal Cancer
BRCA2 mutation
Fallopian Tube Cancer
BRCA2 mutation
Breast Cancer
BRCA2 mutation
Pancreatic Adenocarcinoma
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Prostate Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
HER2 Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Hormone Receptor Positive Breast Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Breast Cancer
BRCA2 mutation
Hormone Receptor Positive Breast Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
NSCLC
BRCA2 mutation
Pancreatic Cancer
BRCA2 mutation
Cholangiocarcinoma
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Endometrial Cancer
BRCA2 mutation
Ovarian Serous Adenocarcinoma
BRCA2 mutation
Prostate Cancer
BRCA2 mutation
CRC
BRCA2 mutation
Urothelial Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
RCC
BRCA2 mutation
Pancreatic Ductal Adenocarcinoma
BRCA2 mutation
Biliary Tract Cancer
BRCA2 mutation
Pancreatic Cancer
BRCA2 mutation
Breast Cancer
BRCA2 mutation
Breast Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
HER2 Negative Breast Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
HER2 Negative Breast Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Solid Tumor
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Solid Tumor
BRCA2 mutation
HER2 Negative Breast Cancer
BRCA2 mutation
HER2 Negative Breast Cancer
BRCA2 mutation
Hormone Receptor Positive Breast Cancer
BRCA2 mutation
Pancreatic Ductal Adenocarcinoma
BRCA2 mutation
Bladder Cancer
BRCA2 mutation
Prostate Cancer
BRCA2 mutation
Colon Cancer
BRCA2 mutation
Pancreatic Cancer
BRCA2 mutation
Prostate Cancer
BRCA2 mutation
Head and Neck Cancer